Geriatric Assessment Improves Outcomes in Older Adults with Lymphoma
Geriatric Assessments: A New Frontier in Treating Older Adults with Lymphoma
New research highlights the importance of geriatric assessments in personalizing treatment for older adults with diffuse large B-cell lymphoma (DLBCL), a common and aggressive type of non-Hodgkin lymphoma (NHL).
Image Credit: angellodeco-stock.adobe.com
A recent study,published in the journal blood,analyzed data from 619 patients over 65 diagnosed with DLBCL between 2010 and 2022. The median age of participants was 73, and most received anthracycline (AC)-based chemotherapy combined with immunotherapy.
The study found that AC-based therapy substantially improved both progression-free survival (PFS) and overall survival (OS) compared to non-AC-based treatments. Older age and higher Eastern Cooperative Oncology Group (ECOG) performance scores, indicating poorer physical function, were linked to worse PFS and OS outcomes.
Geriatric Assessment: A Window into Frailty
Delving deeper, researchers explored the role of comprehensive geriatric assessment (CGA) in predicting outcomes. CGA evaluates various factors beyond traditional performance measures, including cognitive function, nutritional status, and social support.
The study revealed striking differences in survival based on frailty levels persistent by CGA. Frail patients had a median OS of just 9 months, while pre-frail and fit patients showed significantly longer survival. these findings underscore the limitations of relying solely on ECOG scores and highlight the value of CGA in identifying vulnerable patients who may benefit from tailored treatment approaches.
Timed Up and Go Test: A Swift Predictor of Chemotherapy Toxicity
Another study, also published in Blood, focused on the Timed Up and Go (TUG) test, a simple yet effective measure of functional mobility. Researchers prospectively evaluated the TUG test’s ability to predict severe chemotherapy toxicity (STox) in 194 older adults with NHL.
The results were compelling: patients with a TUG time of 12 seconds or more were significantly more likely to experience Stox. Moreover, each additional second on the TUG test increased the odds of experiencing Stox by 11%.This suggests that the TUG test could serve as a valuable tool for identifying patients at higher risk for chemotherapy complications.
Towards Personalized care for Older Adults with Lymphoma
These studies collectively emphasize the need for a more personalized approach to treating older adults with NHL. Incorporating geriatric assessment tools like CGA and the TUG test into routine oncology practise can help clinicians:
Accurately assess frailty and predict treatment risks.
Tailor treatment plans to individual needs and vulnerabilities.
* Minimize chemotherapy toxicity and improve patient outcomes.
By embracing these advancements,oncologists can move towards a future where older adults with lymphoma receive the most effective and safest care possible.
Geriatric Assessments: A New Frontier in Treating Older Adults wiht Lymphoma
NewsDirectory3.com exclusive Interview
New York, NY – Lymphoma, a cancer of the lymphatic system, is often associated with the elderly. While meaningful advances have been made in lymphoma treatments,older adults often face unique challenges due to age-related health complexities. A growing focus on geriatric assessments is changing the landscape of lymphoma care, promising individualized and more effective treatment strategies.
To delve deeper into this exciting growth, NewsDirectory3.com sat down with Dr. Elizabeth Miller, a leading hematologist-oncologist specializing in lymphoma and geriatric oncology at the renowned Memorial Sloan Kettering Cancer Center.
NewsDirectory3.com: Dr. Miller, can you explain why geriatric assessments are gaining importance in the context of lymphoma treatment for older adults?
Dr. Miller: Absolutely. Older adults with lymphoma often have other health conditions, known as comorbidities, which can substantially impact their response to treatment and overall well-being. Traditional treatment approaches frequently enough fail to consider these individual complexities. Geriatric assessments help us paint a comprehensive picture of an individual’s health beyond just their cancer diagnosis.
NewsDirectory3.com: What does a geriatric assessment typically entail?
Dr. Miller: It involves a thorough evaluation of various aspects including physical function, cognitive abilities, nutritional status, social support systems, and medication use. We also consider their overall frailty level, which is a measure of their vulnerability to health stressors.
NewsDirectory3.com: How does this details translate into personalized treatment plans?
Dr. Miller: By understanding an individual’s strengths and vulnerabilities, we can tailor treatment regimens to maximize benefits while minimizing risks. For example, someone with limited physical function might not tolerate aggressive chemotherapy regimens. In such cases, we might explore gentler therapies or consider dose adjustments.
NewsDirectory3.com: Are there any specific examples of how geriatric assessments have led to improved outcomes for older lymphoma patients?
Dr. Miller: Absolutely. Studies have shown that incorporating geriatric assessments leads to more appropriate treatment decisions, reduced hospitalization rates, and ultimately, improved quality of life for older adults with lymphoma.
NewsDirectory3.com: What message would you like to convey to older adults who are facing a lymphoma diagnosis?
Dr. Miller: Don’t hesitate to ask your oncologist about geriatric assessments. Early identification of your unique needs can lead to a more individualized treatment plan, giving you the best possible chance at a positive outcome.
NewsDirectory3.com: Thank you, Dr. Miller, for shedding light on this vital topic.
This interview highlights a critical shift in the approach to lymphoma treatment, emphasizing the need to consider the multifaceted health needs of older adults. Geriatric assessments are proving to be invaluable tools in personalizing care and paving the way for improved outcomes for this vulnerable population.
For further information and resources on lymphoma care for older adults, please visit the National Cancer Institute website and the American Society of Clinical Oncology website.